[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100604578":3},{"organization":4,"armGroups":7,"interventions":7,"overallOfficials":7,"centralContacts":8,"locations":14,"responsibleParty":30,"collaborators":7,"id":34,"slug":35,"hasResults":36,"nctId":37,"briefTitle":38,"officialTitle":39,"acronym":40,"eligibilityCriteria":41,"healthyVolunteers":36,"sex":42,"minAge":43,"maxAge":7,"enrollmentInfo":44,"targetDuration":47,"studyType":48,"phases":7,"briefSummary":49,"conditions":50,"keywords":55,"overallStatus":17,"whyStopped":7,"lastUpdateSubmitDate":59,"lastUpdatePostDateStruct":60,"startDateStruct":63,"completionDateStruct":65,"leadSponsor":67,"locationsCount":68},{"fullName":5,"class":6},"University Hospital Schleswig-Holstein","OTHER",null,[9],{"name":10,"role":11,"phone":12,"phoneExt":7,"email":13},"Laura K Sievers, MD","CONTACT","+49 431 500 23001","Laura.Rakow@uksh.de",[15],{"facility":16,"status":17,"city":18,"state":7,"zip":19,"country":20,"countryCode":21,"cosmosGeoPoint":22,"geoPoint":27,"contacts":28},"University Hospital Schleswig- Holstein","RECRUITING","Kiel","24105","Germany","DE",{"type":23,"coordinates":24},"Point",[25,26],10.13489,54.32133,{"lat":26,"lon":25},[29],{"name":10,"role":11,"phone":12,"phoneExt":7,"email":13},{"type":31,"investigatorFullName":32,"investigatorTitle":33,"investigatorAffiliation":5,"oldNameTitle":7,"oldOrganization":7},"PRINCIPAL_INVESTIGATOR","Laura Katharina Sievers","Principal Investigator","100604578","pilot-project-renal-and-cardiovascular-tertiary-prevention-in-preeclampsia-100604578",false,"NCT07151339","Pilot Project Renal and Cardiovascular Tertiary Prevention in Preeclampsia","Pilotprojekt Renale Und kardiovaskuläre Tertiärprävention Nach Präeklampsie","EagleEye3P","Inclusion Criteria:\n\n* older than 18 yrs\n* diagnosed preeclampsia, HELLP syndrome or kidney disease durig pregnancy\n\nExclusion Criteria:\n\n* unable for informed consent","FEMALE","18 Years",{"count":45,"type":46},100,"ESTIMATED","12 Months","OBSERVATIONAL","Tertiary prevention program for women with preeclampsia, HELLP syndrome, kidney disease and pregnancy or associated conditions, including founding of a biobank. (Observational study since no interference with regular path of treatment suggested in national and international guidelines)",[51,52,53,54],"Preeclampsia","HELLP Syndrome","Eclampsia","Kidney Disease",[56,57,58],"cardiovascular prevention","preeclampsia","pregnancy","2025-08-28",{"date":61,"type":62},"2025-09-03","ACTUAL",{"date":64,"type":62},"2024-11-01",{"date":66,"type":46},"2030-11",{"name":5,"class":6},1]